Literature DB >> 25554372

The complex relationship of race to outcomes in heart failure with preserved ejection fraction.

Jerry H Gurwitz1, David J Magid2, David H Smith3, Grace Hsu4, Sue Hee Sung4, Larry A Allen5, David D McManus6, Robert J Goldberg7, Alan S Go8.   

Abstract

BACKGROUND: An improved understanding of racial differences in the natural history, clinical characteristics, and outcomes of heart failure will have important clinical and public health implications. We assessed how clinical characteristics and outcomes vary across racial groups (whites, blacks, and Asians) in adults with heart failure with preserved ejection fraction.
METHODS: We identified all adults with heart failure with preserved ejection fraction between 2005 and 2008 from 4 health systems in the Cardiovascular Research Network using hospital principal discharge and ambulatory visit diagnoses.
RESULTS: Among 13,437 adults with confirmed heart failure with preserved ejection fraction, 85.9% were white, 7.6% were black, and 6.5% were Asian. After adjustment for potential confounders and use of cardiovascular therapies, compared with whites, blacks (adjusted hazard ratio [HR], 0.72; 95% confidence interval [CI], 0.62-0.85) and Asians (HR, 0.75; 95% CI, 0.64-0.87) had a lower risk of death from any cause. Compared with whites, blacks had a higher risk of hospitalization for heart failure (HR, 1.48; 95% CI, 1.29-1.68); no difference was observed for Asians compared with whites (HR, 1.01; 95% CI, 0.86-1.18). Compared with whites, no significant differences were detected in risk of hospitalization for any cause for blacks (HR, 1.03; 95% CI, 0.95-1.12) and Asians (HR, 0.93; 95% CI, 0.85-1.02).
CONCLUSIONS: In a diverse population with heart failure with preserved ejection fraction, we observed complex relationships between race and important clinical outcomes. More detailed studies of large populations are needed to fully characterize the epidemiologic picture and to elucidate potential pathophysiologic and treatment-response differences that may relate to race.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart failure; Hospitalization; Mortality; Preserved ejection fraction; Race

Mesh:

Year:  2014        PMID: 25554372      PMCID: PMC4442751          DOI: 10.1016/j.amjmed.2014.11.034

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  35 in total

1.  Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity.

Authors:  M Alexander; K Grumbach; L Remy; R Rowell; B M Massie
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

2.  Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

Authors:  Alan S Go; Jingrong Yang; Lynn M Ackerson; Krista Lepper; Sean Robbins; Barry M Massie; Michael G Shlipak
Journal:  Circulation       Date:  2006-06-05       Impact factor: 29.690

3.  Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Anne L Taylor; Jackson T Wright
Journal:  Circulation       Date:  2005-12-06       Impact factor: 29.690

4.  Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial.

Authors:  Melvin R Echols; G Michael Felker; Kevin L Thomas; Karen S Pieper; Jyotsna Garg; Michael S Cuffe; Mihai Gheorghiade; Robert M Califf; Christopher M O'Connor
Journal:  J Card Fail       Date:  2006-12       Impact factor: 5.712

5.  Racial differences in outcome and treatment effect in congestive heart failure.

Authors:  James Mathew; Janet Wittes; Frances McSherry; William Williford; Rekha Garg; Jeffrey Probstfield; Salim Yusuf
Journal:  Am Heart J       Date:  2005-11       Impact factor: 4.749

6.  Outcomes by race and etiology of patients with left ventricular systolic dysfunction.

Authors:  Kevin L Thomas; Mark A East; Eric J Velazquez; Robert H Tuttle; Linda K Shaw; Christopher M O'Connor; Eric D Peterson
Journal:  Am J Cardiol       Date:  2005-10-01       Impact factor: 2.778

7.  Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000.

Authors:  David W Brown; Gail A Haldeman; Janet B Croft; Wayne H Giles; George A Mensah
Journal:  Am Heart J       Date:  2005-09       Impact factor: 4.749

8.  Racial differences in the outcome of left ventricular dysfunction.

Authors:  D L Dries; D V Exner; B J Gersh; H A Cooper; P E Carson; M J Domanski
Journal:  N Engl J Med       Date:  1999-02-25       Impact factor: 91.245

9.  Statin therapy and risks for death and hospitalization in chronic heart failure.

Authors:  Alan S Go; Wendy Y Lee; Jingrong Yang; Joan C Lo; Jerry H Gurwitz
Journal:  JAMA       Date:  2006-11-01       Impact factor: 56.272

10.  Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure.

Authors:  E F Philbin; T G DiSalvo
Journal:  Am J Cardiol       Date:  1998-07-01       Impact factor: 2.778

View more
  6 in total

1.  Racial and Ethnic Differences in Heart Failure Readmissions and Mortality in a Large Municipal Healthcare System.

Authors:  Matthew S Durstenfeld; Olugbenga Ogedegbe; Stuart D Katz; Hannah Park; Saul Blecker
Journal:  JACC Heart Fail       Date:  2016-07-06       Impact factor: 12.035

2.  Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.

Authors:  James P Lash; Ana C Ricardo; Jason Roy; Rajat Deo; Michael Fischer; John Flack; Jiang He; Martin Keane; Claudia Lora; Akinlolu Ojo; Mahboob Rahman; Susan Steigerwalt; Kaixiang Tao; Myles Wolf; Jackson T Wright; Alan S Go
Journal:  Am J Kidney Dis       Date:  2016-05-19       Impact factor: 8.860

Review 3.  Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review.

Authors:  Carolyn L Lekavich; Debra J Barksdale; Virginia Neelon; Jia-Rong Wu
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

4.  Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction.

Authors:  Parag Goyal; Tracy Paul; Zaid I Almarzooq; Janey C Peterson; Udhay Krishnan; Rajesh V Swaminathan; Dmitriy N Feldman; Martin T Wells; Maria G Karas; Irina Sobol; Mathew S Maurer; Evelyn M Horn; Luke K Kim
Journal:  J Am Heart Assoc       Date:  2017-03-29       Impact factor: 5.501

5.  Contemporary Reevaluation of Race and Ethnicity With Outcomes in Heart Failure.

Authors:  Samuel T Savitz; Thomas Leong; Sue Hee Sung; Keane Lee; Jamal S Rana; Grace Tabada; Alan S Go
Journal:  J Am Heart Assoc       Date:  2021-01-21       Impact factor: 5.501

6.  N-terminal pro-B-type natriuretic peptide and prognosis in Caucasian vs. Asian patients with heart failure.

Authors:  Jasper Tromp; Arthur Mark Richards; Wan Ting Tay; Tiew-Hwa K Teng; Poh Shuan Daniel Yeo; David Sim; Fazlur Jaufeerally; Gerard Leong; Hean Yee Ong; Lieng Hsi Ling; Dirk J van Veldhuisen; Tiny Jaarsma; Adriaan A Voors; Peter van der Meer; Rudolf A de Boer; Carolyn S P Lam
Journal:  ESC Heart Fail       Date:  2018-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.